Content is user-generated and unverified.

Pharmacodynamics Notes

B. Pharm IV Semester - Pharmacology 1

1. Introduction to Pharmacodynamics

Definition: Pharmacodynamics is the study of what drugs do to the body - the biochemical and physiological effects of drugs and their mechanisms of action.

Key Question: "What does the drug do to the body?"

Relationship:

  • Pharmacokinetics: What the body does to the drug
  • Pharmacodynamics: What the drug does to the body

2. Drug Receptors

2.1 Definition and Concept

  • Receptor: A macromolecule (usually protein) that binds specifically with a drug to produce a biological response
  • Ligand: Any molecule that binds to a receptor (drugs, hormones, neurotransmitters)

2.2 Types of Drug Receptors

A. Based on Location:

  1. Intracellular Receptors
    • Located inside the cell (cytoplasm or nucleus)
    • Examples: Steroid hormone receptors, thyroid hormone receptors
    • Mechanism: Gene transcription modulation
  2. Cell Surface Receptors
    • Located on cell membrane
    • Most common type for drugs
    • Examples: Adrenergic, cholinergic, histamine receptors

B. Based on Mechanism:

  1. Ion Channel Receptors (Ligand-gated ion channels)
    • Fast response (milliseconds)
    • Examples: Nicotinic acetylcholine receptor, GABA receptor
    • Mechanism: Direct opening/closing of ion channels
  2. G-Protein Coupled Receptors (GPCRs)
    • Moderate response time (seconds to minutes)
    • Most common drug targets (~40% of all drugs)
    • Examples: β-adrenergic, muscarinic, dopamine receptors
    • Mechanism: Activation of second messenger systems
  3. Enzyme-Linked Receptors
    • Slower response (minutes to hours)
    • Examples: Insulin receptor, growth factor receptors
    • Mechanism: Enzymatic activity (usually kinase activity)
  4. Nuclear Receptors
    • Slowest response (hours to days)
    • Examples: Glucocorticoid, estrogen receptors
    • Mechanism: Gene transcription regulation

3. Drug-Receptor Interactions

3.1 Lock and Key Model

  • Receptor has specific binding site
  • Drug must have complementary structure
  • Specificity determines selectivity

3.2 Induced Fit Model

  • Receptor undergoes conformational change upon drug binding
  • More accurate representation of drug-receptor interaction

3.3 Types of Drug-Receptor Binding

A. Reversible Binding

  • Non-covalent bonds: Hydrogen bonds, van der Waals forces, ionic interactions
  • Characteristics: Rapid association and dissociation
  • Example: Most therapeutic drugs

B. Irreversible Binding

  • Covalent bonds: Strong chemical bonds
  • Characteristics: Permanent or very long-lasting binding
  • Example: Aspirin binding to COX enzyme

4. Types of Drug Action

4.1 Based on Receptor Interaction

A. Agonists

  • Definition: Drugs that bind to and activate receptors
  • Full Agonists: Produce maximum possible response
  • Partial Agonists: Produce submaximal response even at high concentrations
  • Inverse Agonists: Produce opposite effect to natural ligand

B. Antagonists

  • Definition: Drugs that bind to receptors but do not activate them

Types of Antagonists:

  1. Competitive Antagonists
    • Compete with agonist for same binding site
    • Reversible
    • Can be overcome by increasing agonist concentration
    • Example: Atropine (muscarinic antagonist)
  2. Non-competitive Antagonists
    • Bind to different site than agonist
    • Irreversible or pseudo-irreversible
    • Cannot be overcome by increasing agonist concentration
    • Example: Phenoxybenzamine (α-adrenergic antagonist)
  3. Uncompetitive Antagonists
    • Bind only to agonist-receptor complex
    • Rare in pharmacology

4.2 Based on Mechanism

A. Receptor-Mediated Actions

  • Direct interaction with specific receptors
  • Most common mechanism

B. Non-Receptor-Mediated Actions

  1. Enzyme Inhibition/Activation
    • Example: Aspirin inhibiting COX
  2. Ion Channel Modulation
    • Example: Calcium channel blockers
  3. Transport Process Interference
    • Example: Cardiac glycosides inhibiting Na+/K+-ATPase
  4. Physicochemical Actions
    • Example: Antacids neutralizing stomach acid

5. Dose-Response Relationships

5.1 Graded Dose-Response Curves

  • X-axis: Log dose of drug
  • Y-axis: Response magnitude
  • Shape: Sigmoid (S-shaped) curve

Important Parameters:

  • ED50/EC50: Dose producing 50% of maximum response
  • Emax: Maximum response achievable
  • Threshold Dose: Minimum dose producing detectable response

5.2 Quantal Dose-Response Curves

  • X-axis: Log dose of drug
  • Y-axis: Percentage of population responding
  • Shape: Sigmoid curve

Important Parameters:

  • ED50: Dose effective in 50% of population
  • TD50: Dose toxic in 50% of population
  • LD50: Dose lethal in 50% of population

5.3 Therapeutic Index (TI)

Formula: TI = TD50/ED50 or LD50/ED50

Interpretation:

  • High TI: Safer drug (wide margin between therapeutic and toxic doses)
  • Low TI: More dangerous drug (narrow margin)

6. Factors Affecting Drug Response

6.1 Drug Factors

  • Dose: Higher doses generally produce greater responses
  • Route of Administration: Affects onset and intensity
  • Formulation: Affects drug release and absorption
  • Drug Interactions: Synergism, antagonism, potentiation

6.2 Patient Factors

A. Physiological Factors

  1. Age
    • Pediatric: Immature organ systems
    • Geriatric: Decreased organ function
  2. Gender: Hormonal differences, body composition
  3. Weight: Affects drug distribution
  4. Pregnancy: Altered pharmacokinetics and safety concerns

B. Pathological Factors

  1. Liver Disease: Affects drug metabolism
  2. Kidney Disease: Affects drug excretion
  3. Cardiovascular Disease: Affects drug distribution
  4. CNS Disorders: May alter drug sensitivity

C. Genetic Factors

  1. Pharmacogenomics: Genetic variations affecting drug response
  2. Enzyme Polymorphisms: CYP450 variations
  3. Receptor Polymorphisms: Altered drug sensitivity

7. Tolerance, Dependence, and Addiction

7.1 Tolerance

Definition: Decreased response to a drug following repeated administration

Types:

  1. Acute Tolerance (Tachyphylaxis): Rapid development within hours
  2. Chronic Tolerance: Develops over days to weeks

Mechanisms:

  • Pharmacokinetic Tolerance: Increased drug metabolism
  • Pharmacodynamic Tolerance: Receptor desensitization/downregulation
  • Behavioral Tolerance: Learned compensatory responses

7.2 Dependence

Physical Dependence: Withdrawal symptoms upon drug discontinuation Psychological Dependence: Craving and compulsive drug-seeking behavior

7.3 Addiction

Complex condition involving compulsive drug use despite harmful consequences

8. Drug Interactions

8.1 Pharmacodynamic Interactions

A. Additive Effects

  • Combined effect equals sum of individual effects
  • Example: Two analgesics with same mechanism

B. Synergistic Effects

  • Combined effect greater than sum of individual effects
  • Example: Alcohol + benzodiazepines (both CNS depressants)

C. Antagonistic Effects

  • One drug opposes the effect of another
  • Example: Naloxone (opioid antagonist) reversing morphine effects

8.2 Types of Antagonism

  1. Functional Antagonism: Different receptors, opposite effects
  2. Chemical Antagonism: Direct chemical interaction
  3. Physiological Antagonism: Opposite physiological effects

9. Quantitative Pharmacology

9.1 Receptor Occupancy Theory

Assumption: Response is proportional to number of receptors occupied

Formula: Response = (Emax × [Drug]) / (KD + [Drug])

Where:

  • Emax = Maximum response
  • [Drug] = Drug concentration
  • KD = Dissociation constant

9.2 Spare Receptors

  • Maximum response achieved without occupying all receptors
  • Provides amplification and sensitivity
  • Common in hormone receptors

9.3 Affinity and Efficacy

  • Affinity: Strength of drug-receptor binding (KD)
  • Efficacy: Ability to activate receptor and produce response
  • Potency: Dose required to produce specific response (related to affinity)

10. Clinical Applications

10.1 Drug Development

  • Understanding pharmacodynamics crucial for drug design
  • Structure-Activity Relationships (SAR)
  • Lead compound optimization

10.2 Personalized Medicine

  • Genetic testing for drug metabolism
  • Tailored dosing based on individual factors
  • Biomarker-guided therapy

10.3 Rational Drug Therapy

  • Choosing appropriate drug based on mechanism
  • Predicting drug interactions
  • Optimizing dosing regimens

11. Important Definitions

Affinity: Tendency of drug to bind to receptor Efficacy: Ability of drug to activate receptor Potency: Amount of drug needed to produce effect Selectivity: Preference for one receptor over another Specificity: Exclusive interaction with one receptor type Bioavailability: Fraction of administered dose reaching systemic circulation Half-life: Time for drug concentration to decrease by 50% Clearance: Volume of plasma cleared of drug per unit time

12. Study Tips for Exams

  1. Understand Concepts: Don't just memorize, understand mechanisms
  2. Practice Curves: Draw and interpret dose-response curves
  3. Know Examples: Associate each concept with specific drug examples
  4. Calculate Parameters: Practice calculating ED50, therapeutic index, etc.
  5. Clinical Correlation: Relate concepts to therapeutic applications
  6. Drug Classifications: Know major drug classes and their mechanisms

13. Common Exam Questions

  1. Compare and contrast different types of drug receptors
  2. Explain the difference between competitive and non-competitive antagonism
  3. Describe factors affecting dose-response relationships
  4. Calculate and interpret therapeutic index
  5. Explain mechanisms of drug tolerance
  6. Discuss pharmacodynamic drug interactions with examples
Content is user-generated and unverified.
    Pharmacodynamics Notes - B. Pharm IV Sem | Claude